Squarepoint’s Bristol-Myers Squibb BMY Stock Holding History

Squarepoint’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.61M	Sell	142,000 -175,600	-55%	-$10.2M	0.01%	1155
2025 Q4	$17.1M	Buy	317,600 +173,100	+120%	+$8.33M	0.02%	814
2025 Q3	$6.52M	Sell	144,500 -21,200	-13%	-$990K	0.01%	1309
2025 Q2	$7.67M	Sell	165,700 -94,700	-36%	-$4.65M	0.01%	1218
2025 Q1	$15.9M	Sell	260,400 -474,900	-65%	-$27.7M	0.02%	804
2024 Q4	$41.6M	Buy	735,300 +312,900	+74%	+$17.5M	0.04%	438
2024 Q3	$21.9M	Sell	422,400 -145,600	-26%	-$6.83M	0.03%	553
2024 Q2	$23.6M	Buy	568,000 +235,500	+71%	+$10.5M	0.04%	510
2024 Q1	$18M	Buy	332,500 +244,300	+277%	+$12.4M	0.03%	666
2023 Q4	$4.53M	Sell	88,200 -449,200	-84%	-$23.6M	0.01%	1456
2023 Q3	$31.2M	Buy	537,400 +471,800	+719%	+$28.9M	0.08%	291
2023 Q2	$4.2M	Sell	65,600 -29,400	-31%	-$1.97M	0.01%	1175
2023 Q1	$6.58M	Sell	95,000 -32,900	-26%	-$2.32M	0.03%	733
2022 Q4	$9.2M	Buy	127,900 +14,800	+13%	+$1.12M	0.04%	534
2022 Q3	$8.04M	Sell	113,100 -60,000	-35%	-$4.35M	0.04%	521
2022 Q2	$13.3M	Buy	173,100 +60,200	+53%	+$4.58M	0.07%	303
2022 Q1	$8.24M	Sell	112,900 -232,100	-67%	-$15.6M	0.04%	507
2021 Q4	$21.5M	Sell	345,000 -200	-0.1%	-$11.7K	0.06%	291
2021 Q3	$20.4M	Buy	345,200 +257,400	+293%	+$17M	0.06%	297
2021 Q2	$5.87M	Sell	87,800 -35,500	-29%	-$2.31M	0.02%	655
2021 Q1	$7.78M	Sell	123,300 -65,000	-35%	-$4.04M	0.05%	451
2020 Q4	$11.7M	Buy	+188,300	New	+$11.6M	0.09%	219
2020 Q1	–	Sell	-3,600	Closed	-$231K	–	1902
2019 Q4	$231K	Sell	3,600 -1,900	-35%	-$109K	﹤0.01%	2166
2019 Q3	$279K	Buy	+5,500	New	+$258K	﹤0.01%	1939

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Squarepoint's BMY Position: Q1 2026 in Review

Squarepoint reduced its Bristol-Myers Squibb (BMY) stake by 89% in Q1 2026, selling an estimated $25.4M and leaving 54,134 shares worth $3.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1817.

Squarepoint first reported a position in BMY in Q1 2015 and has held it in 39 quarters since. The position peaked at $184M in Q4 2023. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Squarepoint held 54,134 shares of Bristol-Myers Squibb worth $3.28M as of Q1 2026.
Squarepoint sold 435,340 Bristol-Myers Squibb shares in Q1 2026, an estimated $25.4M.
Bristol-Myers Squibb made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #1817 holding.
Squarepoint first reported a position in Bristol-Myers Squibb in Q1 2015 and has held it in 39 quarters since.
Squarepoint's Bristol-Myers Squibb position peaked at $184M in Q4 2023.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.